Used in research as a selective antagonist for the GPR55 receptor, IMR-1A helps investigate signaling pathways involved in inflammation, pain, and cancer progression. It is applied in cellular and molecular studies to modulate GPR55 activity and assess downstream biological effects. Due to its role in immune cell regulation, it is also explored for potential therapeutic applications in inflammatory diseases.